Terp, M. G., Jacobsen, K., Molina, M. A., Karachaliou, N., Beck, H. C., Bertran-Alamillo, J., . . . Ditzel, H. J. (2021). Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells. Nature Portfolio.
Style de citation Chicago (17e éd.)Terp, Mikkel G., et al. Combined FGFR and Akt Pathway Inhibition Abrogates Growth of FGFR1 Overexpressing EGFR-TKI-resistant NSCLC Cells. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Terp, Mikkel G., et al. Combined FGFR and Akt Pathway Inhibition Abrogates Growth of FGFR1 Overexpressing EGFR-TKI-resistant NSCLC Cells. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.